Macular Edema Treatment Market by Type (Diabetic Macular Edema, Cystoid Macular Edema), by Treatment Type (Anti-VEGF (Vascular Endothelial Growth Factor), by End User (Hospitals, Ophthalmic Care Institutions, Ambulatory Surgery Centres), by North America (U.S., Canada, Mexico), by Europe (UK, Germany, France, Italy, Spain, Russia, Netherlands, Switzerland, Poland, Sweden, Belgium), by Asia Pacific (China, India, Japan, South Korea, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, New Zealand), by Latin America (Brazil, Mexico, Argentina, Chile, Colombia, Peru), by MEA (UAE, Saudi Arabia, South Africa, Egypt, Turkey, Israel, Nigeria, Kenya) Forecast 2024-2032
The Macular Edema Treatment Market size was valued at USD 17.5 billion in 2023 and is projected to reach USD 40.6 billion by 2032, exhibiting a CAGR of 21.2 % during the forecast period. Macular oedema is an eye condition that results from the accumulation of fluid in the macula, which is a part of the human retina that is responsible for central vision. It is usually linked to diseases such as diabetic retinopathy, retinal vein occlusion, and macular degeneration that affect the elderly. There are two main types: The two types of macular oedema are focal macular oedema in which leakage occurs and diffuse macular oedema; in which leakage occurs in all the layers of the retina. Management methods used in the treatment of wet AMD are anti-VEGF injections, corticosteroids and laser therapy. Anti-VEGF injections maintain the reduction of fluids in the eye and help in enhancing vision through arresting the growth of new blood vessels. Corticosteroids assist in the reduction of inflammatory processes and extravasation of water. Laser therapy cauterizes blood vessels so that they no longer leak or seep more fluid. All these treatments are important in preventing blindness and ensuring that the illness does not progress to worse. The treatment as early as possible improves the quality of life since patients can do their daily routines and minimize the chance of end-stage blindness. These treatments help enhance vision and reduce swelling in the retina, and, thus, lead to a healthier eye.
The increasing prevalence of eye disorders, such as diabetic retinopathy and age-related macular degeneration, is driving the growth of the macular oedema treatment market. Advancements in medical technology and the development of new and more effective treatments are also contributing to market growth.
Aspects | Details |
---|---|
Study Period | 2018-2032 |
Base Year | 2023 |
Estimated Year | 2024 |
Forecast Period | 2024-2032 |
Historical Period | 2018-2023 |
Growth Rate | CAGR of 21.2% from 2018-2032 |
Segmentation |
|
Aspects | Details |
---|---|
Study Period | 2018-2032 |
Base Year | 2023 |
Estimated Year | 2024 |
Forecast Period | 2024-2032 |
Historical Period | 2018-2023 |
Growth Rate | CAGR of 21.2% from 2018-2032 |
Segmentation |
|
Note* : In applicable scenarios
Primary Research
Secondary Research
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.